Mata-Bermudez A, Diaz-Ruiz A, Silva-Garcia L, Gines-Francisco E, Noriega-Navarro R, Rios C
Neurol Int. 2024; 16(6):1509-1527.
PMID: 39585071
PMC: 11587415.
DOI: 10.3390/neurolint16060112.
Xu Y, Li Y, Wang C, Han T, Wu Y, Wang S
Int J Clin Health Psychol. 2024; 24(1):100433.
PMID: 38226005
PMC: 10788816.
DOI: 10.1016/j.ijchp.2023.100433.
Kim J, He M, Widmann A, Lee F
Neuropsychopharmacology. 2023; 49(1):227-245.
PMID: 37673965
PMC: 10700398.
DOI: 10.1038/s41386-023-01717-x.
Chakraborty A, Diwan A
AIMS Neurosci. 2023; 9(4):479-490.
PMID: 36660077
PMC: 9826748.
DOI: 10.3934/Neuroscience.2022027.
Marksteiner J, Defrancesco M, Humpel C
Front Aging Neurosci. 2022; 14:1014305.
PMID: 36247998
PMC: 9557075.
DOI: 10.3389/fnagi.2022.1014305.
Non-motor Symptoms in Parkinson's Disease Patients with Parkin Mutations: More Depression and Less Executive Dysfunction.
Song J, Shen B, Yang Y, Liu F, Zhao J, Tang Y
J Mol Neurosci. 2020; 70(2):246-253.
PMID: 31927768
DOI: 10.1007/s12031-019-01444-3.
Trajectories of maternal depressive and anxiety symptoms from pregnancy to five years postpartum and their prenatal predictors.
Ahmed A, Bowen A, Feng C, Muhajarine N
BMC Pregnancy Childbirth. 2019; 19(1):26.
PMID: 30642277
PMC: 6332639.
DOI: 10.1186/s12884-019-2177-y.
Circuits Regulating Pleasure and Happiness in Bipolar Disorder.
Loonen A, Kupka R, Ivanova S
Front Neural Circuits. 2017; 11:35.
PMID: 28588455
PMC: 5439000.
DOI: 10.3389/fncir.2017.00035.
Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor-containing afferents in the noradrenergic nucleus locus coeruleus: implications for the cognitive limb of the stress response.
Wyrofsky R, Reyes B, Van Bockstaele E
Brain Struct Funct. 2017; 222(7):3007-3023.
PMID: 28255675
PMC: 8340878.
DOI: 10.1007/s00429-017-1381-7.
Circuits Regulating Pleasure and Happiness-Mechanisms of Depression.
Loonen A, Ivanova S
Front Hum Neurosci. 2016; 10:571.
PMID: 27891086
PMC: 5102894.
DOI: 10.3389/fnhum.2016.00571.
The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.
Mustapic M, Maihofer A, Mahata M, Chen Y, Baker D, OConnor D
Hum Mol Genet. 2014; 23(23):6375-84.
PMID: 24986918
PMC: 4222356.
DOI: 10.1093/hmg/ddu332.
Reduced activity restriction buffers the relations between chronic stress and sympathetic nervous system activation.
Ho J, Bordon J, Wang V, Ceglowski J, Kim D, Chattillion E
J Gerontol B Psychol Sci Soc Sci. 2013; 69(3):408-16.
PMID: 23685924
PMC: 3983913.
DOI: 10.1093/geronb/gbt028.
Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.
Terzioglu B, Kaleli M, Aydin B, Ketenci S, Cabadak H, Goren M
Neurochem Res. 2013; 38(8):1726-33.
PMID: 23681605
DOI: 10.1007/s11064-013-1076-2.
Where in the brain is depression?.
Pandya M, Altinay M, Malone Jr D, Anand A
Curr Psychiatry Rep. 2012; 14(6):634-42.
PMID: 23055003
PMC: 3619732.
DOI: 10.1007/s11920-012-0322-7.
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists.
Kirilly E, Hunyady L, Bagdy G
J Neural Transm (Vienna). 2012; 120(1):177-86.
PMID: 22990678
DOI: 10.1007/s00702-012-0900-1.
Neonatal DSP-4 treatment modifies antinociceptive effects of the CB1 receptor agonist methanandamide in adult rats.
Korossy-Mruk E, Kuter K, Nowak P, Szkilnik R, Rykaczewska-Czerwinska M, Kostrzewa R
Neurotox Res. 2012; 23(1):39-48.
PMID: 22488162
PMC: 3526738.
DOI: 10.1007/s12640-012-9323-x.
Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders.
Carvalho A, Van Bockstaele E
Prog Neuropsychopharmacol Biol Psychiatry. 2012; 38(1):59-67.
PMID: 22296986
PMC: 3351574.
DOI: 10.1016/j.pnpbp.2012.01.008.
Pathophysiology of depression and mechanisms of treatment.
Brigitta B
Dialogues Clin Neurosci. 2011; 4(1):7-20.
PMID: 22033824
PMC: 3181668.
The relation between depression and parkin genotype: the CORE-PD study.
Srivastava A, Tang M, Mejia-Santana H, Rosado L, Louis E, Caccappolo E
Parkinsonism Relat Disord. 2011; 17(10):740-4.
PMID: 21856206
PMC: 3221786.
DOI: 10.1016/j.parkreldis.2011.07.008.
Contribution of limbic norepinephrine to cannabinoid-induced aversion.
Carvalho A, Reyes A, Sterling R, Unterwald E, Van Bockstaele E
Psychopharmacology (Berl). 2010; 211(4):479-91.
PMID: 20602088
PMC: 3272334.
DOI: 10.1007/s00213-010-1923-7.